📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma (2021)

First Author: Heinze K

Attributed to: Developing Existing Healthcare Technologies to Deliver More Affordable and Effective Cancer Care funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.09.16.21262993

Publication URI: http://dx.doi.org/10.1101/2021.09.16.21262993

Type: Preprint